Adaptive Biotechnologies Corp
ADPTNasdaqCIK 1478320HealthcareFiscal year ends Dec 31
Reports and events: 113 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-332940 |
| 2026-07-2916:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-323753 |
| 2026-06-2216:07 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-277516 |
| 2026-06-1516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-271117 |
| 2026-06-0916:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-263844 |
| 2026-05-0516:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-206546 |
| 2026-05-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206455 |
| 2026-04-2416:30 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001193125-26-177409 |
| 2026-02-2616:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076902 |
| 2026-02-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-039409 |
| 2026-01-1208:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009840 |
| 2025-12-3008:00 ET | 8-K | 8.01 Other events | 0001193125-25-335921 |
| 2025-11-0516:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-267061 |
| 2025-11-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266974 |
| 2025-08-1808:00 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-182222 |
| 2025-08-0516:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103120 |
| 2025-08-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103058 |
| 2025-06-1216:51 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-140017 |
| 2025-05-0116:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-061897 |
| 2025-05-0116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061851 |
| 2025-04-2916:02 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001193125-25-103752 |
| 2025-03-0316:36 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-030913 |
| 2025-02-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-017915 |
| 2024-11-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123423 |
| 2024-11-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123369 |
| 2024-08-0116:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089342 |
| 2024-08-0116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089301 |
| 2024-06-1116:15 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-24-071913 |
| 2024-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054604 |
| 2024-05-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054513 |
| 2024-04-2616:31 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001193125-24-118168 |
| 2024-04-0917:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-090983 |
| 2024-04-0516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-042291 |
| 2024-04-0216:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-084748 |
| 2024-02-2916:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023095 |
| 2024-02-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-015230 |
| 2023-11-0916:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062136 |
| 2023-11-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062077 |
| 2023-09-0117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-227739 |
| 2023-08-0216:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037234 |
| 2023-08-0216:17 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-037192 |
| 2023-07-0315:14 ET | 8-K | 3.01 Delisting notice | 0001193125-23-181293 |
| 2023-06-1316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-23-027702 |
| 2023-05-0907:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-138915 |
| 2023-05-0316:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017250 |
| 2023-05-0316:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017194 |
| 2023-04-2816:01 ET | DEF 14A | Proxy statement | 0001193125-23-126845 |
| 2023-04-1110:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-097389 |
| 2023-02-1416:32 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-002792 |
| 2023-02-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-002786 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 19:53 ET. Listed shows no prices and gives no investment advice.